BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

511 related articles for article (PubMed ID: 9708812)

  • 1. Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresia.
    Ramm GA; Nair VG; Bridle KR; Shepherd RW; Crawford DH
    Am J Pathol; 1998 Aug; 153(2):527-35. PubMed ID: 9708812
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of hepatic stellate cells and transforming growth factor-beta(1) in cystic fibrosis liver disease.
    Lewindon PJ; Pereira TN; Hoskins AC; Bridle KR; Williamson RM; Shepherd RW; Ramm GA
    Am J Pathol; 2002 May; 160(5):1705-15. PubMed ID: 12000722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of collagens type I and IV, osteonectin and transforming growth factor beta-1 (TGFbeta1) in biliary atresia and paucity of intrahepatic bile ducts during infancy.
    Lamireau T; Le Bail B; Boussarie L; Fabre M; Vergnes P; Bernard O; Gautier F; Bioulac-Sage P; Rosenbaum J
    J Hepatol; 1999 Aug; 31(2):248-55. PubMed ID: 10453937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats.
    Arias M; Sauer-Lehnen S; Treptau J; Janoschek N; Theuerkauf I; Buettner R; Gressner AM; Weiskirchen R
    BMC Gastroenterol; 2003 Oct; 3():29. PubMed ID: 14565855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The slow progression of hepatic fibrosis in intrahepatic cholestasis as compared with extrahepatic biliary atresia.
    Shirahase I; Ooshima A; Tanaka K; Inamoto T; Yamamoto E; Ozawa K; Yamabe H
    Eur J Pediatr Surg; 1995 Apr; 5(2):77-81. PubMed ID: 7612587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic mediators induce fibrogenic effects in normal liver after partial bile duct ligation.
    Osawa Y; Seki E; Adachi M; Taura K; Kodama Y; Siegmund SV; Schwabe RF; Brenner DA
    Liver Int; 2006 Nov; 26(9):1138-47. PubMed ID: 17032415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-17A plays a pivotal role in cholestatic liver fibrosis in mice.
    Hara M; Kono H; Furuya S; Hirayama K; Tsuchiya M; Fujii H
    J Surg Res; 2013 Aug; 183(2):574-82. PubMed ID: 23578751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human Delta-like 1 homologue is implicated in the progression of liver fibrosis in biliary atresia.
    Huang CC; Chuang JH; Huang LL; Chou MH; Wu CL; Chen CM; Hsieh CS; Lee SY; Chen CL
    J Pathol; 2004 Feb; 202(2):172-9. PubMed ID: 14743499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of transforming growth factors actively transcribed during the progress of liver fibrosis in biliary atresia.
    Lee SY; Chuang JH; Huang CC; Chou MH; Wu CL; Chen CM; Hsieh CS; Chen CL
    J Pediatr Surg; 2004 May; 39(5):702-8. PubMed ID: 15137003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective activation of Toll-like receptor 7 in activated hepatic stellate cells may modulate their profibrogenic phenotype.
    Chou MH; Huang YH; Lin TM; Du YY; Tsai PC; Hsieh CS; Chuang JH
    Biochem J; 2012 Oct; 447(1):25-34. PubMed ID: 22765640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ligustrazine Attenuates Liver Fibrosis by Targeting miR-145 Mediated Transforming Growth Factor-
    Qiu JL; Zhang GF; Chai YN; Han XY; Zheng HT; Li XF; Duan F; Chen LY
    J Pharmacol Exp Ther; 2022 Jun; 381(3):257-265. PubMed ID: 35398813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adenoviral delivery of an antisense RNA complementary to the 3' coding sequence of transforming growth factor-beta1 inhibits fibrogenic activities of hepatic stellate cells.
    Arias M; Lahme B; Van de Leur E; Gressner AM; Weiskirchen R
    Cell Growth Differ; 2002 Jun; 13(6):265-73. PubMed ID: 12114216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of selective bile duct ligation on liver parenchyma in young animals: histologic and molecular evaluations.
    Tannuri AC; Coelho MC; de Oliveira Gonçalves J; Santos MM; Ferraz da Silva LF; Bendit I; Tannuri U
    J Pediatr Surg; 2012 Mar; 47(3):513-22. PubMed ID: 22424347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of fas ligand on bile ductule epithelium in biliary atresia--a poor prognostic factor.
    Liu C; Chiu JH; Chin T; Wang LS; Li AF; Chow KC; Wei C
    J Pediatr Surg; 2000 Nov; 35(11):1591-6. PubMed ID: 11083430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. meso-dihydroguaiaretic acid from Machilus thunbergii down-regulates TGF-beta1 gene expression in activated hepatic stellate cells via inhibition of AP-1 activity.
    Park EY; Shin SM; Ma CJ; Kim YC; Kim SG
    Planta Med; 2005 May; 71(5):393-8. PubMed ID: 15931574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of osteopontin correlates with portal biliary proliferation and fibrosis in biliary atresia.
    Whitington PF; Malladi P; Melin-Aldana H; Azzam R; Mack CL; Sahai A
    Pediatr Res; 2005 Jun; 57(6):837-44. PubMed ID: 15845635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In situ expression of fibrogenic growth factors and their receptors in biliary atresia: comparison between early and late stages.
    Faiz Kabir Uddin Ahmed A; Ohtani H; Nio M; Funaki N; Iwami D; Kumagai S; Sato E; Nagura H; Ohi R
    J Pathol; 2000 Sep; 192(1):73-80. PubMed ID: 10951403
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal activation of OPN inflammation pathway in livers of children with biliary atresia and relationship to hepatic fibrosis.
    Huang L; Wei MF; Feng JX
    Eur J Pediatr Surg; 2008 Aug; 18(4):224-9. PubMed ID: 18704890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conditional tetracycline-regulated expression of TGF-beta1 in liver of transgenic mice leads to reversible intermediary fibrosis.
    Ueberham E; Löw R; Ueberham U; Schönig K; Bujard H; Gebhardt R
    Hepatology; 2003 May; 37(5):1067-78. PubMed ID: 12717387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are stable postoperative biliary atresia patients really stable?
    Kobayashi H; Horikoshi K; Yamataka A; Lane GJ; Furuhata A; Sueyoshi N; Miyano T
    Pediatr Surg Int; 2001 Mar; 17(2-3):104-7. PubMed ID: 11315264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.